Search

Becton Dickinson and Co

Open

SectorGezondheidszorg

198.89 0.64

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

196.93

Max

198.45

Belangrijke statistieken

By Trading Economics

Inkomsten

759M

449M

Verkoop

269M

5B

K/W

Sectorgemiddelde

46.209

50.373

EPS

3.23

Dividendrendement

2.11

Winstmarge

9.011

Werknemers

72,000

EBITDA

540M

1.2B

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

-3.07% downside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

2.11%

2.12%

Volgende Winsten

5 nov 2026

Volgende dividenddatum

30 dec 2026

Volgende Ex Dividend datum

7 dec 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

7.9B

53B

Vorige openingsprijs

198.25

Vorige sluitingsprijs

198.89

Becton Dickinson and Co Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 okt 2026, 00:01 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, reaching its highest level of the day and well above its 20-day moving average.

30 okt 2026, 21:51 UTC

Becton Dickinson and Co shares advanced modestly in after-market trading, continuing a strong performance that began shortly after the market closed.

29 okt 2026, 23:01 UTC

Becton Dickinson and Co shares are lower in after-market hours, reflecting broader market declines despite stronger-than-expected Q3 GDP growth.

28 okt 2026, 20:13 UTC

Becton Dickinson and Co shares advanced modestly in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

27 okt 2026, 19:16 UTC

Becton Dickinson and Co shares are declining, marking three consecutive lower daily closes, despite earlier rebounding from a session low.

26 okt 2026, 20:13 UTC

Becton Dickinson and Co's shares traded modestly lower during after-market hours on Monday, following a period of relative stability since the market closed.

24 okt 2026, 00:02 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month trading range.

23 okt 2026, 23:21 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month trading range.

22 okt 2026, 23:01 UTC

Becton Dickinson and Co shares fell in after-market trading, now at their lowest point of the day, moving lower since Thursday's close.

21 okt 2026, 19:56 UTC

Becton Dickinson and Co is experiencing a modest increase, currently positioned above its 20-day moving average and near the upper end of its one-month range.

20 okt 2026, 23:21 UTC

Correlated Moves

Becton Dickinson shares declined in after-market hours, influenced by disappointing earnings from holdings like Intuitive Surgical and Abbott Laboratories, amid broader sector weakness.

19 okt 2026, 22:21 UTC

Becton Dickinson and Co's shares rose in after-market trading, closing near session highs and reflecting a cumulative gain since Monday's close.

17 okt 2026, 00:01 UTC

Becton Dickinson and Co shares are modestly lower in after-market trading following a drop shortly after Friday's close.

16 okt 2026, 23:11 UTC

Becton Dickinson and Co shares are modestly lower in after-market trading, continuing a gradual decline from Friday's close while remaining above the 20-day moving average.

15 okt 2026, 20:02 UTC

Becton Dickinson and Co's shares are advancing amid significant gains in the Health Care Equipment sub-sector, remaining well above their 20-day moving average.

14 okt 2026, 23:51 UTC

Becton Dickinson shares are lower in after-market trading, reflecting a broader market decline amid renewed losses in semiconductor stocks and rising inflation concerns.

13 okt 2026, 19:46 UTC

Becton Dickinson and Co shares fell modestly after an early peak, reflecting typical performance for this time of day, while remaining above the 20-day moving average.

12 okt 2026, 22:01 UTC

Becton Dickinson and Co. shares declined modestly during after-market hours, continuing earlier losses amid unusual volatility and fluctuations in trading activity.

8 okt 2026, 20:01 UTC

News

Becton Dickinson advocates for reducing maternal mortality rates at the UN General Assembly, emphasizing advanced monitoring technologies for childbirth complications.

7 okt 2026, 19:50 UTC

News

Becton Dickinson shares fell sharply after Barclays initiated coverage with an Underweight rating and set a price target of $165, overshadowing positive trial results.

6 okt 2026, 21:51 UTC

News

Becton Dickinson and Co shares declined in after-market trading after Barclays initiated coverage with an Underweight rating and a $165.00 price target.

5 okt 2026, 20:31 UTC

Becton Dickinson and Co is experiencing a deeper decline in after-market trading, now modestly lower since Monday's close and near the lower end of its one-month range.

2 okt 2026, 19:26 UTC

Becton Dickinson and Co shares fell, continuing a trend of weaker closes over the past four sessions, remaining significantly below their 20-day moving average.

1 okt 2026, 20:07 UTC

Becton Dickinson and Co's shares fell, marking a fourth consecutive day of declines, closing below Wednesday's level and its 20-day moving average.

30 sep 2026, 20:20 UTC

Becton Dickinson and Co is trading modestly lower in after-market hours, continuing a decline below its recent trend and significantly under its 20-day moving average.

29 sep 2026, 20:07 UTC

Becton Dickinson and Co's shares are declining, reflecting a broader market trend, despite an earlier rebound from a session low.

28 sep 2026, 19:15 UTC

Becton Dickinson and Co shares fell slightly, trading around the midpoint of their one-month range after fluctuating earlier in the session.

25 sep 2026, 22:55 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, reflecting upward movement from Friday's close, amid flat U.S. durable goods orders for August.

24 sep 2026, 19:06 UTC

Becton Dickinson and Co shares fell sharply, reversing from an earlier peak and currently near the low end of their one-month range.

22 sep 2026, 20:07 UTC

Becton Dickinson and Co is advancing, having gained ground since Monday's close, despite pulling back slightly from an earlier session peak.

Peer Vergelijking

Prijswijziging

Becton Dickinson and Co Prognose

Koersdoel

By TipRanks

-3.07% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 191.8 USD  -3.07%

Hoogste 210 USD

Laagste 165 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Becton Dickinson and Co - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

10 ratings

4

Buy

5

Hold

1

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
help-icon Live chat